|
OMIM |
Link |
Information gain |
01 |
|
EPO
|
[NCBI]
|
0.0114881
|
|
|
CDAN2
|
[NCBI]
|
0.00799017
|
|
|
CDAN3
|
[NCBI]
|
0.00427114
|
|
|
DBA
|
[NCBI]
|
0.00200112
|
|
|
porphyria, congenital erythropoietic
|
[NCBI]
|
0.00108797
|
|
|
transient erythroblastopenia of childhood
|
[NCBI]
|
0.000860189
|
|
|
anemia, dyserythropoietic congenital, type i
|
[NCBI]
|
0.000496973
|
|
|
HBFQTL2
|
[NCBI]
|
0.000421627
|
|
|
EPOR
|
[NCBI]
|
0.000352878
|
|
|
GATA1
|
[NCBI]
|
0.000245339
|
|
|
KLF1
|
[NCBI]
|
0.00023396
|
|
|
protoporphyria, erythropoietic
|
[NCBI]
|
0.000180917
|
|
|
erythrocytosis, familial, 2
|
[NCBI]
|
0.00015634
|
|
|
EGF
|
[NCBI]
|
0.000140324
|
|
|
ECYT4
|
[NCBI]
|
0.000135428
|
|
|
ovalocytosis, hereditary hemolytic, with defective erythropoiesis
|
[NCBI]
|
0.000135428
|
|
|
TIMP1
|
[NCBI]
|
0.000118746
|
|
|
dyserythropoiesis, congenital, with internuclear chromatin bridges and ultrastructurally normal erythroblast heterochromatin
|
[NCBI]
|
0.000107678
|
|
|
sickle cell anemia
|
[NCBI]
|
0.000104763
|
|
|
deafness, sensorineural, and male infertility
|
[NCBI]
|
9.72177e-05
|
|
|
majeed syndrome
|
[NCBI]
|
9.72177e-05
|
|
|
thrombocytopenia, platelet dysfunction, hemolysis, and imbalanced globin synthesis
|
[NCBI]
|
9.72177e-05
|
|
|
CHH
|
[NCBI]
|
9.54549e-05
|
|
|
KITLG
|
[NCBI]
|
8.67796e-05
|
|
|
INHBA
|
[NCBI]
|
8.55634e-05
|
|
|
anemia, hypochromic microcytic
|
[NCBI]
|
8.5394e-05
|
|
|
beta thalassemia, dominant inclusion body type
|
[NCBI]
|
8.5394e-05
|
|
|
erythroleukemia, familial
|
[NCBI]
|
8.1383e-05
|
|
|
porphyria cutanea tarda
|
[NCBI]
|
7.8348e-05
|
|
|
CF
|
[NCBI]
|
7.78537e-05
|
|
|
VEGF
|
[NCBI]
|
7.59198e-05
|
|
|
PRL
|
[NCBI]
|
6.6332e-05
|
|
|
erythrocytosis, familial, 1
|
[NCBI]
|
6.50744e-05
|
|
|
cyclic hematopoiesis
|
[NCBI]
|
6.50744e-05
|
|
|
ERAF
|
[NCBI]
|
6.37937e-05
|
|
|
chromosome 5q deletion syndrome
|
[NCBI]
|
6.21457e-05
|
|
|
MAEA
|
[NCBI]
|
5.78361e-05
|
|
|
bartter syndrome, type 3
|
[NCBI]
|
5.35257e-05
|
|
|
feline leukemia virus subgroup c receptor
|
[NCBI]
|
4.92121e-05
|
|
|
JAK2
|
[NCBI]
|
4.70574e-05
|
|
|
NFE2
|
[NCBI]
|
4.65287e-05
|
|
|
FA
|
[NCBI]
|
4.51211e-05
|
|
|
locus control region, beta
|
[NCBI]
|
4.43523e-05
|
|
|
NFE2L1
|
[NCBI]
|
4.2521e-05
|
|
|
HBQ1
|
[NCBI]
|
4.09404e-05
|
|
|
HHT
|
[NCBI]
|
3.87379e-05
|
|
|
MIRN222
|
[NCBI]
|
3.45854e-05
|
|
|
MIRN221
|
[NCBI]
|
3.45854e-05
|
|
|
CEACAM5
|
[NCBI]
|
3.25623e-05
|
|
|
asthma, susceptibility to
|
[NCBI]
|
3.25543e-05
|
|
|
HMBS
|
[NCBI]
|
3.09658e-05
|
|
|
IL3
|
[NCBI]
|
2.98971e-05
|
|
|
TNF
|
[NCBI]
|
2.98578e-05
|
|
|
HBG1
|
[NCBI]
|
2.92457e-05
|
|
|
HBB
|
[NCBI]
|
2.88827e-05
|
|
|
RPS19
|
[NCBI]
|
2.76565e-05
|
|
|
sialomucin cd164
|
[NCBI]
|
2.63555e-05
|
|
|
TRIM10
|
[NCBI]
|
2.63555e-05
|
|
|
DYRK4
|
[NCBI]
|
2.63555e-05
|
|
|
ALPS
|
[NCBI]
|
2.56997e-05
|
|
|
VHL
|
[NCBI]
|
2.55204e-05
|
|
|
HGF
|
[NCBI]
|
2.38474e-05
|
|
|
PCNA
|
[NCBI]
|
2.36073e-05
|
|
|
SMAP1
|
[NCBI]
|
2.32603e-05
|
|
|
TRG1
|
[NCBI]
|
2.32603e-05
|
|
|
DYRK3
|
[NCBI]
|
2.12565e-05
|
|
|
DYRK2
|
[NCBI]
|
2.12565e-05
|
|
|
RUNX1
|
[NCBI]
|
2.07719e-05
|
|
|
STRC
|
[NCBI]
|
1.9771e-05
|
|
|
CATSPER2
|
[NCBI]
|
1.9771e-05
|
|
|
TFRC
|
[NCBI]
|
1.86087e-05
|
|
|
MAFK
|
[NCBI]
|
1.85909e-05
|
|
|
CDAN1
|
[NCBI]
|
1.85909e-05
|
|
|
CD163
|
[NCBI]
|
1.85909e-05
|
|
|
ZFPM1
|
[NCBI]
|
1.85909e-05
|
|
|
CAT
|
[NCBI]
|
1.79038e-05
|
|
|
MAFG
|
[NCBI]
|
1.76125e-05
|
|
|
KLF11
|
[NCBI]
|
1.76125e-05
|
|
|
HIPK3
|
[NCBI]
|
1.76125e-05
|
|
|
LPIN2
|
[NCBI]
|
1.67774e-05
|
|
|
MYST3
|
[NCBI]
|
1.67774e-05
|
|
|
DNASE2
|
[NCBI]
|
1.67774e-05
|
|
|
OTX1
|
[NCBI]
|
1.60496e-05
|
|
|
LIG1
|
[NCBI]
|
1.60496e-05
|
|
|
PRDX2
|
[NCBI]
|
1.60496e-05
|
|
|
NPPA
|
[NCBI]
|
1.54814e-05
|
|
|
ICSBP1
|
[NCBI]
|
1.5405e-05
|
|
|
NCOR1
|
[NCBI]
|
1.5405e-05
|
|
|
MPO
|
[NCBI]
|
1.5294e-05
|
|
|
BUB1B
|
[NCBI]
|
1.48268e-05
|
|
|
GATA2
|
[NCBI]
|
1.48268e-05
|
|
|
SLC11A2
|
[NCBI]
|
1.47908e-05
|
|
|
ADAR
|
[NCBI]
|
1.29766e-05
|
|
|
EPAS1
|
[NCBI]
|
1.25975e-05
|
|
|
EIF2C2
|
[NCBI]
|
1.22432e-05
|
|
|
PPARBP
|
[NCBI]
|
1.22432e-05
|
|
|
RB1
|
[NCBI]
|
1.19828e-05
|
|
|
CBFA2T1
|
[NCBI]
|
1.19108e-05
|
|
|
JMJD6
|
[NCBI]
|
1.19108e-05
|
|
|
KEL
|
[NCBI]
|
1.19108e-05
|
|
|
TAL1
|
[NCBI]
|
1.15979e-05
|
|
|
HLF
|
[NCBI]
|
1.15979e-05
|
|
|
IL9
|
[NCBI]
|
1.13024e-05
|
|
|
ID2
|
[NCBI]
|
1.13024e-05
|
|
|
CASP3
|
[NCBI]
|
1.05043e-05
|
|
|
GATA4
|
[NCBI]
|
1.05043e-05
|
|
|
HSPA1A
|
[NCBI]
|
1.02633e-05
|
|
|
UROS
|
[NCBI]
|
1.00331e-05
|
|
|
HIPK2
|
[NCBI]
|
9.8129e-06
|
|
|
DFFA
|
[NCBI]
|
9.8129e-06
|
|
|
FOXO3A
|
[NCBI]
|
9.3992e-06
|
|
|
THRA
|
[NCBI]
|
9.01707e-06
|
|
|
TNFSF10
|
[NCBI]
|
8.93354e-06
|
|
|
SLE
|
[NCBI]
|
8.69994e-06
|
|
|
E2F1
|
[NCBI]
|
8.66235e-06
|
|
|
PTK2
|
[NCBI]
|
8.62164e-06
|
|
|
G6PD
|
[NCBI]
|
8.52962e-06
|
|
|
SLC40A1
|
[NCBI]
|
8.49419e-06
|
|
|
STAT5A
|
[NCBI]
|
8.43297e-06
|
|
|
anemia, sideroblastic, x-linked
|
[NCBI]
|
8.02224e-06
|
|
|
AFP
|
[NCBI]
|
7.93647e-06
|
|
|
coproporphyria
|
[NCBI]
|
7.73173e-06
|
|
|
FANCC
|
[NCBI]
|
7.45817e-06
|
|
|
SLC16A1
|
[NCBI]
|
7.076e-06
|
|
|
TFR2
|
[NCBI]
|
6.95543e-06
|
|
|
TF
|
[NCBI]
|
6.68934e-06
|
|
|
MAPK14
|
[NCBI]
|
6.50321e-06
|
|
|
RA
|
[NCBI]
|
6.4667e-06
|
|
|
ALAD
|
[NCBI]
|
6.29342e-06
|
|
|
HBG2
|
[NCBI]
|
6.29342e-06
|
|
|
THPO
|
[NCBI]
|
4.56309e-06
|
|
|
SLC4A1
|
[NCBI]
|
4.24441e-06
|
|
|
PARP1
|
[NCBI]
|
4.06596e-06
|
|
|
MYC
|
[NCBI]
|
3.68234e-06
|
|
|
AQP1
|
[NCBI]
|
3.63096e-06
|
|
|
PTH
|
[NCBI]
|
3.49675e-06
|
|
|
GAPDH
|
[NCBI]
|
3.39181e-06
|
|
|
IL2
|
[NCBI]
|
2.6837e-06
|
|
|
UCP2
|
[NCBI]
|
2.17087e-06
|
|
|
STAT1
|
[NCBI]
|
1.49698e-06
|
|
|
LEP
|
[NCBI]
|
1.2704e-06
|
|
|
ADA
|
[NCBI]
|
1.0821e-06
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
1.07466e-06
|
|
|
TNFSF6
|
[NCBI]
|
1.00401e-06
|
|
|
PF4
|
[NCBI]
|
6.6492e-07
|
|
|
ACE
|
[NCBI]
|
4.1463e-07
|
|
|
PI
|
[NCBI]
|
5.01297e-08
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
1.12773e-08
|
|
|
CP
|
[NCBI]
|
2.99276e-09
|
|
|
INS
|
[NCBI]
|
6.19631e-11
|
|